The importance of a cluster of conserved aromatic residues of human epidermal growth factor (hEGF) to the receptor binding epitope is suggested by the interaction of His10 and Tyr13 of the A-loop with Tyr22 and Tyr29 of the N-terminal β-sheet to form a hydrophobic surface on the hEGF protein. Indeed, Tyr13 has previously been shown to contribute a hydrophobic determinant to receptor binding. The roles of His10, Tyr22 and Tyr29 were investigated by structure-function analysis of hEGF mutant analogues containing individual replacements of each residue. Substitutions with aromatic residues or a leucine at position 10 retained receptor affinities and agonist activities similar to wild-type indicating that an aromatic residue is not essential. Variants with polar, charged or aliphatic substitutions altered in size and/or hydrophobicity exhibited reduced binding and agonist activities. 1-Dimensional 1 H NMR spectra of high, moderate and low-affinity analogues at position 10 suggested only minor alterations in hEGF native structure. In contrast, a variety of replacements were tolerated at position 22 or 29 indicating that neither aromaticity nor hydrophobicity of Tyr22 and Tyr29 is required for receptor binding. CD spectra of mutant analogues at position 22 or 29 indicated a correlation between loss of receptor affinity and alterations in hEGF structure. The results indicate that similar to Tyr13, His10 of hEGF contributes hydrophobicity to the receptor binding epitope, whereas Tyr22 and Tyr29 do not appear to be directly involved in receptor interactions. The latter conclusion, together with previous studies, suggests that hydrophobic residues on only one face of the N-terminal β-sheet of hEGF are important in receptor recognition.
Introduction
Epidermal growth factor (EGF) is a 6 kDa polypeptide mitogen that binds with high affinity to a specific cell-surface receptor thereby activating the receptor's intrinsic protein-tyrosine kinase. The activated receptor phosphorylates cytoplasmic substrates initiating a signal transduction cascade that ultimately leads to DNA synthesis and cell proliferation (see reviews by Carpenter and Cohen, 1990; Ullrich and Schlessinger, 1990; Cadena and Gill, 1992; van der Geer et al., 1994) .
EGF is composed of 53 amino acid residues and contains three intramolecular disulfide bonds. The A-loop and B-loop in the N-terminal domain and the C-loop in the C-terminal domain are generated by the disulfide bonds Cys6-Cys20, Cys14-Cys31 and Cys33-Cys42, respectively. The threedimensional solution structure of EGF has been determined by NMR (see reviews by Campion and Niyogi, 1994; Groenen et al., 1994) . The EGF protein folds into a conformation with two slightly overlapping structural domains corresponding to residues 1-35 and 30-53. The N-terminal domain is characterized by a three-stranded anti-parallel β-sheet and the C-terminal domain contains a minor β-sheet.
Analysis of site-directed mutants of EGF has revealed amino acid residues in both the N-and C-terminal domains that are important for EGF receptor (EGFR) recognition (see reviews by Campion and Niyogi, 1994; Groenen et al., 1994) . Based on high resolution NMR data, these residues are positioned to form three discontinuous binding sites on one face of the EGF molecule. In the C-terminus, Leu47 has been shown to be a key EGFR binding determinant (Burgess et al., 1988; Engler et al., 1988; Ray et al., 1988; Moy et al., 1989; Dudgeon et al., 1990; Matsunami et al., 1990 Matsunami et al., , 1991 . Ile23, Leu26 and Ala30 are important residues in the major β-sheet Koide et al., 1992a,b) while Tyr13 and Leu15 contribute hydrophobic determinants in the N-terminus (Tadaki and Niyogi, 1993; Nandagopal et al., 1996) . Thus, hydrophobic residues interspersed throughout the EGF molecule play a key role in EGFR recognition. Analysis of EGFR affinities of double-site mutants has revealed that these sites act independently of one another (Campion et al., 1993a) . The binding site defined by Tyr13 and Leu15 also includes the highly conserved Arg41 which is spatially defined between these two critical hydrophobic residues at the interface between the N-and C-terminal domains ( Figure 1A) . Indeed, the guanidinium moiety of Arg41 has been shown to be a critical determinant of EGFR interaction (Engler et al., , 1992 .
The potential importance of a cluster of aromatic residues in the N-terminal domain of EGF was first demonstrated by NMR studies which predicted that these solvent-exposed residues provide a hydrophobic surface on the EGF protein (Mayo et al., 1986) . The residues included in this aromatic cluster of hEGF are His10, Tyr13, Tyr22 and Tyr29 ( Figure  1A ). As indicated above, the importance of hydrophobicity of Tyr13 in EGFR recognition has been established in previous studies (Tadaki and Niyogi, 1993) . A role for the residue at position 10 is suggested by the conservation among EGF species of a histidine or a tyrosine at this position and its close proximity to Tyr13 as determined by NMR (Mayo et al., 1986;  Kohda et al., 1988; Cooke et al., 1990; Hommel et al., 1992; Kohda and Inagaki, 1992; Montelione et al., 1992) . The importance of His10 of hEGF is further underscored by a report indicating that the corresponding residue, His12, of the related EGFR ligand, human transforming growth factor alpha (hTGFα), forms part of the EGFR binding interface (McInnes et al., 1996) . Aromaticity at positions 22 and 29 is also conserved among EGF species. Based on NMR studies, Tyr22 and Tyr29 are paired directly opposite one another on one face of the N-terminal β-sheet ( Figure 1B) . In previous studies of these residues, reduced EGFR binding affinities, relative to wild-type hEGF, were observed for the mutant analogues, Y22D and Y29G, (Engler et al., 1988; Campion et al., 1990) suggesting possible roles of Tyr22 and Tyr29 in EGFR recognition. However, a decrease in conformational stability of these analogues was suggested by the presence of multiple peaks in their HPLC elution profiles, a factor that may have contributed to the reduction in EGFR affinity.
In order to determine whether His10, Tyr22 and Tyr29 of hEGF are important in EGFR recognition, site-directed mutagenesis was used to individually introduce a variety of amino acid replacements at each position [preliminary results of these studies were reported earlier in abstract form (Tadaki et al., 1994; Murray and Niyogi, 1995) ]. EGFR binding affinities of the mutant analogues were assessed by a radioreceptor competition binding assay and agonist activities were measured by an EGFR tyrosine kinase stimulation assay. Possible structural alterations were examined by NMR or CD spectroscopy of selected mutant analogues at each position. These studies identify His10 of hEGF as an important residue of the hydrophobic EGFR binding epitope and provide evidence for the involvement of only one face of the N-terminal β-sheet of hEGF in EGFR recognition.
Materials and methods

Site-directed mutagenesis of hEGF
Oligonucleotides utilized for mutagenesis were synthesized with a Milligen/Biosearch Cyclone Plus DNA synthesizer using phosphoramidite chemistry, or purchased from Integrated DNA Technologies. Site-directed mutants were generated by a PCR strategy (Helmsley et al., 1989) using the doublestranded hEGF expression vector (pNsiI) as the template. pNsiI is a derivative of pCAS (Campion et al., 1993a) containing an NsiI site engineered into the hEGF coding region. Each mutagenic oligonucleotide primer was used in a 'back to back' configuration with a wild-type reverse primer. Pyrococcus furiosus DNA polymerase (Pfu polymerase, Stratagene) was used to incorporate the mutagenic primer and amplify the hEGF-containing template. The PCR reactions (0.1 ml) were carried out in buffer [20 mM Tris-HCl, pH 8.2, 10 mM KCl, 6 mM (NH 4 ) 2 SO 4 , 2 mM MgCl 2 , 0.1% Triton X-100 and 10 µg/ml bovine serum albumin (BSA)] supplied by the manufacturer and contained 100 pmol each of mutagenic and reverse primers, 0.2 mM dNTPs, 0.01 pmol template DNA and 5 U Pfu polymerase. Conditions for the first PCR cycle were as follows: denaturation at 94°C for 3 min, annealing at 45°C for 1 min and primer extension at 72°C for 12 min. Twentyfive successive cycles were performed under the same conditions except that the denaturation time was reduced to 1 min. The 2.6 kb PCR product was agarose gel-purified, treated with T4 polynucleotide kinase (USB) to phosphorylate the 5Ј ends and circularized by treatment overnight with T4 DNA ligase (New England Biolabs) at 14°C. Transformation of Escherichia coli JM107 was done according to the procedure of Hanahan (1985) . All engineered mutations as well as the absence of any undesired alterations were confirmed by DNA sequencing (Sanger et al., 1977) of the entire hEGF gene using Sequenase (USB).
Expression and purification of recombinant hEGF proteins
Wild-type and mutant hEGF analogues were expressed as periplasmic proteins in E.coli JM107 and purified by (NH 4 ) 2 SO 4 precipitation, size-exclusion chromatography and reversed-phase HPLC as described previously (Engler et al., 1988; Campion et al., 1990) . HPLC fractions were lyophilized and stored at -80°C for use in our studies. The wild-type and mutant hEGF proteins were judged to be homogeneous after analysis by nondenaturing/nonreducing polyacrylamide gel electrophoresis.
Radioreceptor competition binding assay
Membrane-bound EGFR was isolated from A431 (human epidermoid carcinoma) cells according to Akiyama et al. (1985) with modifications described by Campion et al. (1990) . Binding of hEGF to EGFR was measured using the procedure described by Carpenter (1985) for EGF binding to membranebound EGFR in cell-free extracts. Radioiodinated wild-type hEGF was prepared by the chloramine-T method (Hunter and Greenwood, 1962) to a specific activity of 1.5-4ϫ10 5 c.p.m./ pmol using carrier-free sodium [ 125 I] iodide purchased from Amersham. For the competition assay, the A431 membrane preparation (2 µg total protein) was incubated with radioiodinated wild-type hEGF at a concentration sufficient to just saturate the EGFR in the absence or presence of various concentrations of unlabeled wild-type or mutant hEGF protein.
The reactions were carried out in 20 mM HEPES, pH 7.4, and 0.1% BSA (w/v) in a total volume of 0.1 ml in microfuge tubes or 96-well plates. The binding reactions were allowed to reach equilibrium for 30 min at 30-37°C, then filtered on cellulose-acetate (GVWP, Millipore) filters or on celluloseacetate filtration plates (GV, Millipore) using the Multiscreen Assay System (Millipore). After unbound ligand was removed with 20 mM HEPES, pH 7.4, containing 0.1% BSA, the filters were dried and radioactivity was quantitated by liquid scintillation spectrometry. Bound radioiodinated wild-type hEGF measured in the presence of 1000-fold excess unlabeled wild-type hEGF provided a measure of the nonspecific background (3-10% of total bound radioactivity) and was subtracted from all other values.
EGFR tyrosine kinase stimulation assay
The ability of wild-type and mutant hEGF proteins to stimulate the tyrosine kinase activity of EGFR was determined by measuring the incorporation of 32 P from [γ-32 P]ATP (ICN) into the synthetic polypeptide substrate (Glu 4 ,Tyr 1 ) n (average M r of 35 000, Sigma). EGFR from A431 cell membranes was solubilized and partially purified by wheat germ agglutininagarose (USB) chromatography according to the procedure of Akiyama et al. (1985) . The EGFRs were preincubated with various concentrations of wild-type or mutant hEGF protein for 15 min at room temperature under conditions similar to those described previously (Akiyama et al., 1985; Engler et al., 1988; Koland and Cerione, 1988) . Preincubation in the absence of hEGF served as the control. The reactions were carried out in microfuge tubes or 96-well plates and contained 20 mM HEPES, pH 7.4, 250 mM NaCl, 2 mM MnCl 2 , 10 mM MgCl 2 , 1 mM dithiothreitol (DTT), 250 mM (NH 4 ) 2 SO 4 , 0.1 mM Na 3 VO 4 , 5% glycerol, 0.5 mM PMSF, 0.05% Triton X-100 and 0.5-1 µg of EGFR in a final volume of 0.1 ml. The tyrosine kinase reaction was initiated by the addition of [γ-32 P]ATP (0.2-0.5 Ci/mmol) and (Glu 4 ,Tyr 1 ) n to final concentrations of 75-100 µM and 0.5 mg/ml, respectively. The reactions were incubated at room temperature for 10 min and stopped by the addition of ice-cold 5% trichloroacetic acid (TCA) and 10 mM sodium pyrophosphate to the microfuge tubes or 25% TCA and 50 mM sodium pyrophosphate to the 96-well plates. Following a 10 min incubation on ice, the acid-insoluble material was filtered on HAWP (Millipore) filters or multiscreen filtration plates (HA, Millipore) and washed with 5% TCA and 10 mM sodium pyrophosphate. The filters were dried and radioactivity was quantitated by liquid scintillation spectrometry. Radioactivity incorporated in the absence of hEGF was subtracted from the hEGF-stimulated values. NMR spectroscopy Purified wild-type and mutant hEGF samples were prepared for NMR experiments by repeated lyophilization and dissolution in 2 H 2 O to a final concentration of 1.6 mM. The pH was adjusted to 3.4 or 7.2-7.4 (uncorrected for deuterium isotope effect). All NMR spectra were obtained on a widebore Bruker AMX 400 MHz spectrometer at 27°C. Onedimensional data sets were collected over a spectral width of 4807 Hz with an acquisition time of 3.4 s. Quadrature phase detection and a 90°observation pulse of 6.7-7 µs were used. 32K data points of 64-128 transients were collected. Data were processed with 0.5-1 Hz line broadening before Fourier transformation. Chemical shifts were referenced to 2,2-dimethyl-2-sila-pentane-5-sulfonate.
CD measurements
The concentrations of the protein samples were quantitated from the absorbance of the peptide bond at 215 nm according to the method of Prasad et al. (1985) . Square quartz cuvettes with a 1 mm path length were used. CD measurements were made from 215 to 260 nm on a Jasco J-500C spectropolarimeter with a scan rate of 5 nm/min and a time constant of 8 s. For each sample, four scans were averaged and smoothed by fitting with the CONTIN program (Provencher and Glöckner, 1981) . Y29L was used as a negative control by reduction with 10 mM DTT overnight at room temperature. The DTT was removed by passing the treated protein through a Biogel P-2 column (equilibrated in and eluted with 10 mM sodium phosphate, pH 7.2).
Results
Relative EGFR binding affinities of hEGF analogues
As a measure of binding affinity, the concentration of hEGF variant necessary to compete with 50% of radioiodinated wildtype hEGF for EGFR binding (IC 50 ) was determined as described in Materials and methods; relative binding affinities were determined from the ratio of wild-type to mutant IC 50 values (Table I ). Representative competition binding curves for the mutant analogues at position 10 are shown in Figure 2 . Substitution with aromatic residues resulted in mutants H10Y, H10W and H10F, with relative binding affinities of 130, 110 and 71% of wild-type, respectively (Table I) . Replacements with aliphatic residues, H10L, H10A and H10V, retained 59, 22 and 12% of wild-type binding activity, respectively. Substitution with polar (H10Q and H10S) or basic (H10K) residues generated mutants with 18% of wild-type binding activity while H10E displayed the most dramatic loss in affinity retaining only 5% of wild-type activity.
Representative competition binding curves for the mutant analogues at position 22 or 29 are shown in Figure 3 . Y22W exhibited 115% of wild-type EGFR affinity while Y22F and Y29F retained 76 and 64% of wild-type binding activity, respectively (Table I) . Substitutions with a leucine or an alanine residue at either position retained 50-62% of wild-type affinity. Y22K had 129% of wild-type affinity, whereas Y29K retained only 30% of wild-type activity. Similarly, Y22P retained high (85%) EGFR affinity while Y29P displayed only 13% of wildtype activity. As mentioned above, we had previously found that Y22D and Y29G had lower EGFR affinities, 8 and 17%, respectively, as compared with wild-type hEGF (Engler et al., 1988; Campion et al., 1990) .
Relative agonist activities of hEGF analogues
Interaction of hEGF with EGFR results in activation of the intrinsic protein-tyrosine kinase of EGFR. As an additional means of assessing the relative EGFR affinities of the mutant analogues, an in vitro kinase assay was used with partially purified EGFR from A431 cell membranes (Akiyama et al., 1985; Koland and Cerione, 1988; Engler et al., 1988 ) and a synthetic substrate, (Glu 4 ,Tyr 1 ) n , to determine the concentration of each hEGF analogue required for half-maximal stimulation of EGFR kinase activity (EC 50 ). Relative agonist activities are presented in Table I as the ratio of wild-type to mutant EC 50 values. Representative stimulation curves are shown in Figures 4 and 5. In general, the relative agonist activities paralleled the relative binding affinities. H10Y, H10W, H10F and H10L displayed agonist activities close to or somewhat greater than wild-type, whereas H10A, H10Q, H10S, H10K, H10V and H10E exhibited agonist activities ranging from 9 to 40% of wild-type (Table I) . Similarly, the effects of mutation of Tyr22 or Tyr29 exhibited a trend comparable to that seen with the radioreceptor competition assay. Relative agonist activities ranged from 49 to 113% of wild-type hEGF, except for Y22D and Y29G with values of 8 and 17%, respectively. The kinase stimulation assay could not be performed with Y29P due to the extremely low yields of this protein and the high concentrations needed to accurately measure the half maximal value for kinase activation. Despite the decreased agonist activities of some of the hEGF mutants, at saturating concentrations all analogues stimulated EGFR tyrosine kinase activity to a level similar to that observed for wild-type hEGF, indicating that the maximal extent of activation of EGFR was not impaired by these substitutions.
NMR analysis of selected mutant hEGF analogues at position 10
We have previously utilized 1-dimensional (1-D) 1 H NMR to analyze the structural consequences of amino acid substitutions in site-directed mutants of hEGF Matsunami et al., 1991; Campion et al., 1993b; Nandagopal et al., 1996) . In particular, the resonance frequencies of the aromatic protons in these spectra are diagnostic of the molecular conformations of the mutant analogues due to the distribution of these aromatic residues throughout the three-dimensional (3-D) structure of hEGF (see reviews by Campion and Niyogi, 1994; Groenen et al., 1994) . Because the 3-D structure of EGF is largely independent of pH over the range pH 2-8 (Kohda et al., 1991; Kohda and Inagaki, 1992) , previous studies have been performed both at acidic pH, to obtain optimal spectral resolution, and at neutral pH, to mimic physiological (assay) conditions. To assess the potential structural consequences of substitutions at position 10, high (H10L), moderate (H10A) and lowaffinity (H10E) analogues were analyzed by 1-D 1 H NMR at pH 3.4 and 7.2-7.4. Comparison of the H10L and wild-type spectra at acidic pH revealed similarities in the aromatic resonances from 6.7-7.0 and 7.2-7.6 p.p.m. (Figure 6A ). Based on published assignments at acidic pH (Campion et al., 1993b) , the majority of these peaks in the wild-type spectrum correspond to protons of Trp49 and Trp50, as well as δH of His16 and Tyr37 and εH of Tyr13 and Tyr44 (Figure 7) . Because of the similarity of the spectra in these regions, the assignments for wild-type hEGF could be extended to H10L. In contrast, significant differences relative to wild-type were observed in the H10L spectrum in the aromatic regions from 6.2-6.7 and 7.0-7.2 p.p.m. at acidic pH ( Figure 6A ). Included within these regions of the wild-type spectrum are all of the aromatic resonances of Tyr22 and Tyr29 as well as the δH resonances of Tyr13 and Tyr44 and the εH peaks of Tyr37 (Figure 7) . Similar results were observed when comparing the wild-type and H10L spectra at neutral pH; no significant changes were seen in the regions from 6.7-7.0 and 7.2-7.6 p.p.m., whereas differences were observed in the regions from 6.2-6.7 and 7.0-7.2 p.p.m. (Figure 6B ). Our preliminary assignment of the aromatic resonances of wild- type hEGF at neutral pH (Murray et al., 1996; unpublished data) suggests that the same resonances are altered in the H10L spectra at both pH values.
Similar to H10L, the H10A spectra exhibited no significant changes at either pH relative to wild-type in the regions from 6.7-7.0 and 7.2-7.6 p.p.m. (Figure 6A and B) . Likewise, resonances that were altered by the leucine substitution were also affected by replacement with an alanine residue ( Figure  6A and B, 6.2-6.7 and 7.0-7.2 p.p.m.). The H10E spectrum at acidic pH was very similar to the corresponding spectrum of H10L suggesting that these two analogues have similar conformations ( Figure 6A ). However, the two spectra diverged at neutral pH, with the H10E spectrum exhibiting additional chemical shift changes relative to wild-type in the region from 6.7-7.2 p.p.m. (Figure 6B ).
In summary, 1-D NMR analyses of these analogues reveal that mutation of His10 of hEGF results in chemical shift changes corresponding primarily to residues located proximal to position 10, whereas more distal residues experience fewer changes or are not significantly affected.
CD spectra of selected mutant hEGF analogues at position 22 or 29
In order to determine whether changes in EGFR affinity of position 22 or 29 mutants correlated with altered hEGF structure, several analogues were analyzed using differential CD measurements. Although this method is not as sensitive as NMR in revealing fine detail, CD spectra are nevertheless useful in detecting gross structural changes. NMR spectra of mutants involving tyrosine substitutions can be difficult to interpret because significant ring current effects can result in conformation-independent changes in chemical shifts (Perkins, 1982) .
Wild-type hEGF was scanned from 215 to 260 nm and the CD spectrum is shown in Figure 8A . A major positive peak was observed between 220 and 240 nm. This profile is similar to that obtained by Holladay et al. (1976) for mouse EGF (mEGF) and is indicative of the overall native structure of EGF. CD spectra of the mutant analogues, Y22D, Y22K, Y22L, Y29K and Y29L, were also measured. Wild-type hEGF was used to zero the instrument base line and the mutants were scanned against this base line to generate the difference spectra ( Figure 8B ). In a control experiment, the difference spectrum of DTT-treated Y29L was generated which showed a profile considerably shifted from that of wild-type hEGF ( Figure 8B ). A major negative peak was observed at~226 nm similar to the results of Holladay et al. (1976) for unfolded (by 8.5 M guanidinium hydrochloride) mEGF. The difference spectra of Y22K, Y29K and Y29L showed some negative fluctuations compared with the wild-type spectrum, whereas the Y22L spectrum exhibited positive peaks. The difference spectrum of Y22D was the most significantly altered with a shape similar to that of reduced Y29L. Fig. 7 . Expansion of the spectra from Figure 6A . The sequence-specific resonance assignments for wild-type (WT) hEGF (Campion et al., 1993b) are shown in order to permit comparison with the H10L, H10A and H10E analogues. 
Discussion
The importance of His10, Tyr22 and Tyr29 of hEGF in forming part of the EGFR binding epitope was investigated by structurefunction analysis of hEGF mutant analogues with individual replacements of each residue. Polarity of the His10 side-chain was shown to be nonessential by the reduced EGFR affinities of H10Q and H10S. H10E showed the lowest binding affinity of all the mutants analyzed indicating that a negatively-charged side-chain at position 10 is not tolerated. H10K also showed a decrease in affinity suggesting that protonation of the His10 imidazole ring is not essential for binding activity. Indeed, this result is consistent with the pK a value of 6.5 for His10 (Murray et al., 1996) which predicts that~90% of this residue will be unprotonated at the pH (pH 7.4) of the functional assays.
Replacement of His10 with aromatic residues resulted in analogues that retained or slightly exceeded EGFR affinity relative to wild-type; however, replacement with the γ-branched aliphatic residue, leucine, also produced a variant with significant retention of EGFR affinity indicating that aromaticity is not essential for binding. This result is reminiscent of studies with Tyr13 of hEGF where Y13L retained high EGFR affinity (Hommel et al., 1991; Tadaki and Niyogi, 1993) . Replacement of His10 with the β-branched aliphatic residue, valine, generated an analogue with significantly reduced binding affinity, although molecular modeling (Biosym Insight II, not shown) of energy-minimized H10V suggests the possibility of steric interactions between a valine at position 10 and Tyr13, which may have contributed to the lowered affinity of this analogue. Similarly, H10A showed a reduction in EGFR affinity indicating that the decreased size and/or hydrophobicity of an alanine side-chain relative to a histidine at position 10 reduced favorable binding interactions. Together, these results indicate that hydrophobicity of His10 contributes to hEGF-EGFR binding.
1-Dimensional NMR analyses of H10L, H10A and H10E indicated that substitutions at position 10 of hEGF resulted in chemical shift changes corresponding primarily to residues located proximal to the site of mutation. In interpreting the NMR data, it is important to note that chemical shifts are very sensitive to even minor changes in conformation. Accordingly, the spectral changes observed for H10L probably reflect only minor structural alterations since this mutant retains considerable EGFR affinity. Ring current effects due to loss of the imidazole ring of histidine (Perkins, 1982) may also account in part for the changes observed in these spectra. Importantly, no significant additional changes were observed in the H10A spectra relative to H10L, suggesting that no additional structural alterations had occurred in this mutant. The impairment in the binding activity of H10A could therefore reflect changes in the mutant's interaction with EGFR due to the introduction of a smaller and less hydrophobic residue at position 10. Likewise, the similar spectra for H10L and H10E at acidic pH indicated that there were no significant differences in conformation between these two analogues. Therefore, the variations in the H10E and H10L spectra at neutral pH probably reflect the effects of deprotonation of the glutamate residue at position 10 of H10E rather than significant structural differences between these mutants. The dramatic loss in EGFR affinity of H10E could therefore indicate changes in the interaction of this analogue with EGFR due to the presence of a negative charge at position 10. We cannot exclude the possibility, however, that some structural alterations in H10E, albeit minor, may have also contributed towards the loss in EGFR affinity.
Substitution of Tyr22 with a phenylalanine residue generated an analogue which showed no significant change in EGFR affinity. Y22L also showed no substantial loss in affinity indicating that similar to residues 10 and 13, an aromatic moiety at position 22 is not essential for EGFR binding. No dramatic loss in EGFR affinity was observed for Y22A indicating that a large hydrophobic side-chain is also not required at this position. The loss in binding activity of Y22D and the increased binding affinity of Y22K are consistent with NMR studies that place Tyr22 in proximity to the acidic residues, Asp3, Glu5, Glu24 and Asp27. Y22P showed no significant loss in EGFR affinity indicating that a proline residue is tolerated at position 22.
Similar to the position 22 mutant analogues, Y29F, Y29L and Y29A retained substantial EGFR affinity demonstrating that neither aromaticity nor hydrophobicity is necessary at position 29 for EGFR binding. The activities of Y29K and Y29P differed dramatically from similar position 22 mutants; Y29K exhibited a moderate decrease in EGFR affinity while Y29P retained only 13% of wild-type activity. Tryptophan and aspartate residues were apparently not readily accommodated at position 29 as expression of the Y29W and Y29D mutants did not yield measurable protein products. Among the position 29 variants, only Y29P showed an abnormal HPLC elution profile (not shown), similar to Y29G (Engler et al., 1988) .
Interestingly, the corresponding residue at position 29 of TGFα is a proline in both human and rat. A proline at position 29 of TGFα has been postulated to introduce a right-handed twist of approximately 90°into the molecule as determined by NMR Tappin et al., 1989; Kline et al., 1990) . The introduction of such a 'kink' into Y29P may disrupt some of the hydrogen bonds of the β-sheet and/or physically displace critical β-sheet residues. NMR studies have demonstrated that some of the hydrogen bonds of the β-sheet of EGF are not present in TGFα Mayo et al., 1989) , suggesting the selective importance of these hydrogen bonds in EGF-EGFR interactions. Although EGF and TGFα bind to EGFR with similar affinities (see review by Groenen et al., 1994) , there are known differences in their binding characteristics for EGFR that may lead to differences in their activities (Schreiber et al., 1986; Barrandon and Green, 1987; French et al., 1995) . Richter et al. (1995) have shown that the N-terminal β-sheet of hTGFα is important in EGFR binding and enables the chicken EGFR to selectively bind hTGFα over mEGF.
CD measurements were made to determine whether changes in EGFR affinity of the position 22 or 29 mutant analogues could be correlated with possible structural alterations. Holladay et al. (1976) showed that the overall structure of EGF could be monitored by examining the CD spectrum between 220 and 235 nm. The spectrum above 225 nm was produced primarily by achirality generated by the three intramolecular disulfide bonds, as well as the side-chain chromophores from aromatic residues like tryptophans and tyrosines. The peptide groups, mainly of β-sheets, made the major contribution to the CD profile below 225 nm.
The difference spectrum of DTT-treated Y29L exhibited a large negative fluctuation(s) indicative of severe disruption of native structure due to the reduction of the disulfide bonds. The difference spectrum of native Y29L demonstrated the least deviation from the baseline in the region below 225 nm suggesting little effect on the integrity of the major β-sheet and the overall structure; this is consistent with the retention of substantial EGFR affinity, about 60% of wild-type. The difference spectrum of Y29K was similar to that of Y29L except for more negative fluctuations in the region below 225 nm, changes that may have contributed to the lower EGFR affinity, 30% of wild-type. Alterations relative to wild-type in the Y29L and Y29K difference spectra above 225 nm were relatively minor compared with the spectrum of reduced Y29L and most likely reflected the loss of aromatic chromophores rather than significant disruption of native conformation. Unfortunately, Y29G and Y29P, which showed greatly reduced EGFR affinities, were produced in such low amounts in our protein expression system as to preclude measurement of their CD spectra. However, the altered HPLC elution profiles of these mutants suggested loss of native structure. This is not too surprising since the total elimination of a large tyrosine side-chain in Y29G would be expected to cause a substantial change in the conformation of the major β-sheet which serves as a backbone of the native EGF structure. Likewise, introduction of a proline residue at position 29 might also cause significant changes in β-sheet structure.
The difference spectrum of Y22L exhibited a positive peak in the region below 225 nm, suggesting a possible change in β-sheet orientation. However, this change did not significantly affect EGFR affinity as Y22L maintained 62% of wild-type activity. Y22K also displayed some changes in its difference spectrum possibly corresponding to β-sheet and other peptide groups and yet retained wild-type EGFR affinity. The changes observed in the Y22L and Y22K spectra above 225 nm were relatively small and were most likely due to loss of aromatic chromophores. The Y22D spectrum was similar to that of reduced Y29L, both in the shape of the curve and the magnitude of the difference from wild-type. A fairly large change in mean ellipticity was observed between 215 and 225 nm, suggesting a major disruption of the β-sheet. In the region from 225 to 235 nm, the change observed for Y22D was too great to be attributed solely to the loss of the tyrosine chromophore when compared with the other position 22 mutants. Thus, significant alterations in conformation correlate with the reduced EGFR affinity observed for Y22D.
The importance of hydrophobicity in defining the EGFR binding epitope of EGF has been well established (see reviews by Campion and Niyogi, 1994; Groenen et al., 1994) . The hydrophobic residues that have been identified in previous studies (Tyr13, Leu15, Ile23, Leu26 and Leu47) define a multisite binding domain on one face of the EGF molecule. The results of the present study indicate that His10 of hEGF contributes another hydrophobic determinant to the EGFR binding domain. Thus, His10 joins Tyr13 as a residue in the A-loop whose hydrophobicity, similar to the B-and C-loops, plays an important role in EGFR recognition. The proximity of His10 to the binding site defined by Tyr13, Leu15 and the crucial Arg41, strongly suggests that His10 contributes hydrophobicity to this site of EGFR recognition. Comparison of His10 of hEGF to the corresponding residue, His12, of hTGFα suggests that the latter probably also contributes hydrophobicity to EGFR recognition. Reduced EGFR affinities and mitogenic activities have been observed upon mutation of His12 to alanine, lysine or proline (Defeo-Jones et al., 1988 Feild et al., 1992) and the pK a value of 5.8 for His12 (Tappin et al., 1989) indicates that it is also predominantly unprotonated at physiological pH.
In contrast to His10 and Tyr13, Tyr22 and Tyr29 do not appear to be directly involved in EGFR recognition since a variety of substitutions are tolerated at either site. Therefore, the role of Tyr22 and Tyr29 may be limited to providing structural determinants in the N-terminal β-sheet of hEGF. Previous analysis of other β-sheet residues indicates that Glu24 and Asp27 are also not important in EGFR binding (Engler et al., 1988) . These residues are located on the same face of the β-sheet as Tyr22 and Tyr29 ( Figure 1B) . However, Ile23, Leu26 and Ala30 of the opposite face of the β-sheet have been shown to play important roles in EGFR recognition Koide et al., 1992a,b) . Thus, only one face of the N-terminal β-sheet of hEGF appears to be critical to EGFR recognition.
The present studies as well as previous results (Tadaki and Niyogi, 1993) indicate that aromaticity of His10, Tyr13, Tyr22 or Tyr29 is not essential for hEGF-EGFR interactions. Similarly, previous studies indicate that aromaticity of the highly conserved tyrosine residue at position 37 of hEGF is not required for EGFR binding (Engler et al., , 1991 . What is the reason for the conservation of aromaticity of these residues? For Tyr37, a role in maintaining some structural feature(s) common to all EGF-like species has been postulated. This hypothesis is based on the fact that position 37 is conserved as a tyrosine residue even in molecules that contain EGF-like domains and are thought to adopt conformations similar to hEGF, but do not bind EGFR. Moreover, hEGF analogues with non-aromatic substitutions at position 37 exhibit altered reverse-phased HPLC profiles indicating the presence of misfolded forms of the protein (our unpublished observations). The role of aromaticity of His10, Tyr13, Tyr22 and Tyr29 is less clear. Structural studies of non-aromatic substitutions at 1049 these sites suggest that just a lack of aromaticity is not sufficient to produce significant effects on hEGF conformation. However, we cannot rule out the possibility that aromaticaromatic interactions within the cluster play a role in the folding and stability of the EGF protein (Holladay et al., 1976; Burley and Petsko, 1985; Mayo et al., 1986) . Alternatively, there may be other EGFR-independent roles for aromaticity of this cluster such as processing of the EGF precursor form or metabolism of the EGF protein.
In addition to the lack of a requirement for aromaticity, the acid-base character of His10 is also not essential for EGFR recognition. Yet, position 10 of some species of EGF is conserved as a histidine residue. One possible role for the ionization state of His10 may be in intracellular trafficking of the hEGF-EGFR complex. hEGF, mEGF and TGFα exhibit different EGFR affinities at endosomal pH (pH 6), which results in differences in trafficking between these ligands (Ebner and Derynck, 1991; French et al., 1995) . The difference in pH sensitivity of EGFR binding has been suggested to be related to the number of histidine residues in each ligand. Thus, His10 of hEGF may play an important role in trafficking as well as in cell-surface EGFR interactions.
